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Understanding how Salmonella species establish successful infections remains a foremost research priority. This gastrointestinal
pathogen not only faces the hostile defenses of the host’s immune system, but also faces fierce competition from the large
and diverse community of microbiota for space and nutrients. Salmonella have solved these challenges ingeniously. To jump-
start growth, Salmonella steal hydrogen produced by the gastrointestinal microbiota. Type 3 effector proteins are subsequently
secreted by Salmonella to trigger potent inflammatory responses, which generate the alternative terminal electron acceptors
tetrathionate and nitrate. Salmonella exclusively utilize these electron acceptors for anaerobic respiration, permitting metabolic
access to abundant substrates such as ethanolamine to power growth blooms. Chemotaxis and flagella-mediated motility enable
the identification of nutritionally beneficial niches.The resulting growth blooms also promote horizontal gene transfer amongst the
residentmicrobes.Within the gastrointestinal tract there are opportunities for chemical signaling betweenhost cells, themicrobiota,
and Salmonella. Host produced catecholamines and bacterial autoinducers form components of this chemical dialogue leading
to dynamic interactions. Thus, Salmonella have developed remarkable strategies to initially shield against host defenses and to
transiently compete against the intestinal microbiota leading to successful infections. However, the immunocompetent host is
subsequently able to reestablish control and clear the infection.
1. Introduction
Salmonella is a major pathogen of the gastrointestinal tract.
Our understanding of the cellular andmolecularmechanisms
bywhich Salmonella causes disease has been greatly advanced
in recent years. In parallel, over the past decade there have
been remarkable insights made into our understanding of the
human microbiota and its importance in health and disease.
Much of this work has largely been descriptive but it has
provided essential knowledge on the composition of these
communities. For example, the composition of the intestinal
microbiota has been determined and provided insightful
correlations to health and a variety of disease states, including
infections caused by bacterial pathogens. Recently there
have been surprising revelations on the dynamic interactions
between Salmonella and the intestinal microbiota, as they
both compete for essential nutrients and space.The gastroin-
testinal tract provides a rich and hospitable environment for
the microbiota, but the host defends this territory fiercely
against invading bacterial pathogens. Remarkably, the hosts
frontline defense system is exploited by Salmonella, to inad-
vertently fuel the “battle of the bugs” and promote a transient
growth bloom of Salmonella at the expense of the microbiota
and also in detriment to the host. Ultimately, the host is able
to successfully reestablish control and clear the infection.This
review will provide an introduction on our knowledge and
understanding of the biology and pathogenicity of Salmonella
and subsequently focus on some of the latest research devel-
opments that have provided vivid insights into the dynamic
interactions between S. Typhimurium, the resident intestinal
microbiota, and the gastrointestinal tract.
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2. Salmonella: A Model Enteric Pathogen
Thebiology and virulence of Salmonellahave been intensively
studied, providing vivid insights into the mechanisms by
which this ingenious pathogen causes disease in mammalian
hosts. Key aspects of the virulence mechanisms are discussed
below in the context of the biology of Salmonella.
2.1. Salmonella Are Major Global Pathogens. Salmonellae are
Gram-negative facultative intracellular bacterial pathogens,
which can infect a broad range of animals [1, 2]. Salmonella
are rod-shaped bacteria varying in size from about 2 to 3𝜇m
by 0.4 to 0.6 𝜇m, and their rod shape is maintained by an
actin-like bacterial cytoskeleton [3, 4]. Salmonella species
cause an extensive spectrum of disease in humans from
mild gastroenteritis to life-threatening Typhoid fever [5].
Salmonellosis remains amajor global health problem causing
significant morbidity and mortality. Annually there are 16
million cases of Typhoid fever, 1 billion cases of gastroenteri-
tis, and 3 million deaths across the globe.
Most species can infect a broad range of hosts as is the case
for Salmonella enterica serovar Typhimurium (S. Typhimuri-
um), but other serotypes such as S. Typhi, S. Pullorum, and
S. Gallinarum are exquisitely host-restricted [6]. Infections
in humans lead to acute gastroenteritis, manifested with the
clinical symptoms of abdominal pains, nausea, diarrhea, and
vomiting. The organisms most frequently associated with
this diarrheal disease are S. Typhimurium and S. enterica
serovar Enteritidis (S. Enteritidis) and are the leading agents
responsible for acute gastroenteritis [7]. In healthy individu-
als salmonellosis is a self-limiting infection but in the young,
the elderly, or the immunosuppressed, Salmonella infections
can lead to severe complications and possibly death. In such
individuals the infection can spread systemically following
breach of the gastrointestinal tract and internalization within
phagocytes [8]. Cephalosporins and fluoroquinolones are the
preferred antibiotics for treatment of these patients [9].
Salmonella Species Are Antigenically and Genetically Diverse.
The Salmonella genus is divided into two species Salmonella
bongori and Salmonella enterica. The species Salmonella
enterica is divided further into six subspecies. Based on
the presence of distinct surface antigens salmonellae can be
divided into over 2500 serovars based on the scheme estab-
lished by Kauffman and White a century ago [10]. These
include flagellar H antigens, somatic lipopolysaccharide O
antigens, and virulence (Vi capsular K antigens [10]. From
these six subspecies, Salmonella enterica subspecies enterica
represents 60% of the 2500 serovars [10], is most often linked
with disease, and is the most diverse. Using whole genome
sequence analysis, S. enterica subspecies enterica could be
subdivided into two populations, namely, clade A and clade
B, reflecting differences in host and tissue tropisms and
metabolism [11].
Achtman and colleagues have also recently used an
alternative DNA sequence based approach to investigate
by serology [12]. Using multilocus sequence-based typing
(MLST) to identify evolutionary relationships, the authors
designated the term eBurst groups (eBGs) to signify closely
related genetic clusters. Some eBGs matched serovars but
many of the clusters identified surprisingly contained mul-
tiple serovars. These results clearly suggest that serovar
classifications may misdirect epidemiologists and clinicians
investigating Salmonella outbreaks and that a DNA-based
approach for classification is much needed [12].
The Escherichia coli (E. coli) and Salmonella enterica
(S. enterica) diverged approximately 100 million years ago
and their genomes differ by 10%. The S. enterica serovars
core genomes differ by less than 1% with each other. They
are just under 5Mb in size and encode for approximately
4,500 genes [11, 13, 14]. The genomes of the enterics have
been under intense selective pressures and this is evident
in their mosaic genomes. Salmonella have acquired blocks
of DNA referred to as Salmonella pathogenicity islands
(SPIs) as they encode genes important for virulence [15].
The GC content of this DNA differs from the core genome
and the pathogenicity island appears to be integrated into
redundant tRNA genes [16]. This suggests they may have
been derived from a different bacterial species. Pathogenicity
islands provide “quantum leaps” in evolution of bacteria by
providing preassembled packages of virulence genes [17].
There are approximately 20 SPIs in Salmonella distributed
around the circular chromosome [18]. In addition there
is further genetic diversity provided by plasmids, islets,
prophages, and phage remnants. Superimposed on top of this
variation, Salmonella can undergo genomic rearrangements
involving recombination between different rRNA operons
and insertion sequences [19, 20].
Chronic Asymptomatic Carriage. In some individuals infec-
tion with S. Typhi can lead to chronic asymptomatic carriage
[21].These individuals shed large numbers of bacteria in their
feces and can subsequently transmit the pathogen to na¨ıve
hosts by contamination of food and water sources. The most
famous carrier case is Mary Malone, who was a cook in New
York in the early 1900s and became known as “TyphoidMary”
as she transmitted the infection to many others. Livestock
have also been identified as carriers, and shedding may play
a vital role in epidemics [22, 23].
Emergence and Spread of Multidrug Resistant and Hyper-
Virulent Strains.The health and economic burden of this dis-
ease is likely to increase due to the rise in multidrug resistant
strains and the emergence of new “hyper-virulent” variants
[24]. Dougan and colleagues have investigated the emergence
in sub-Saharan Africa of a highly invasive nontyphoidal
Salmonella (iNTS) strain ST313, a variant of S. Typhimurium
[24]. Rather than remaining largely localized around the
intestines this variant can now breach the intestinal barrier
and colonize humans systemically. Furthermore, the strain
appears to have spread from human to human rather than
as a zoonosis. Using the power of whole genome sequencing,
the investigators observed two distinct lineages of iNTS that
appeared approximately 52 to 35 years earlier, correlating in
time with the HIV epidemic and treatment of the iNTS with
chloramphenicol. Furthermore the strains had accumulated
pseudogenes, rather like the invasive and host-restricted S.
Typhi responsible for Typhoid fever. These pseudogenes may
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have promoted the systemic spread of the strains and disease
[24, 25]. Thus, immunodeficiency and widespread antibiotic
use have been powerful selective forces in the emergence of
these highly virulent and drug-resistant strains [24].
The multidrug resistant S. Typhimurium DT104 has been
responsible for global epidemics during the 1990s [26].
DT104 was found to be resistant to ampicillin, chloramphen-
icol, streptomycin, sulphonamides, and tetracycline and the
resistance type is referred to with the acronym ACSSuT
[26]. The genes encoding the antibiotic resistance were
found to be chromosomally encoded within a locus termed
Salmonella genomic island (SGI-1), which is a 43 kb integron
[27]. It was popularly believed that this DT104 epidemic
was largely a zoonotic infection acquired from eating food
products derived from cattle. Using a unique collection of 200
DT104 isolates from a limited geographical area of Scotland,
obtained over a 20-year timeframe, Nick Thomson and
colleagues began their molecular detective work [28]. Using
whole genome sequencing, they investigated the associations
between the strains and antibiotic resistance genes [28].
The phylogenetic relationships were established using whole
genome sequencing. The results were epidemiologically sur-
prising and provided overwhelming evidence to suggest
that contrary to popular belief, the S. Typhimurium DT104
epidemic strains and antibiotic resistance genes were main-
tained largely independently within human and food ani-
mal epidemics, with limited exchange. Antibiotic resistance
genes can be transferred horizontally to recipient bacteria
as will be discussed in a later section. The authors observed
an equally high variability in antibiotic resistance profiles
between human and animal isolates.These findings highlight
the importance of collecting genotypic data to facilitate
our understanding of the ecological basis of epidemics and
thus enabling the correct implementation of targeted control
measures [28].
Colonization Beyond Animals. There is an increasing body
of evidence to suggest that Salmonella can infect nonanimal
hosts and colonize agriculturally important plants [29]. In
fact many Salmonella serovars can attach to plants more
strongly than the infamous Escherichia coli 0157:H7 [30].
Following attachment, Salmonella can colonize internal plant
tissues using virulence genes, which also play an important
role in the colonization of animal hosts [31]. Transmission of
Salmonella from raw fruit and vegetables to humans is now
being increasingly recognized as a major proportion of the
reported cases of food poisoning in the United States [32].
2.2. The Infectious Cycle of Salmonella
The Intestinal Phase. Infections with Salmonella are normally
acquired by ingestion of contaminated food and water. Once
ingested Salmonella encounter the acidic pH of the stomach
which induces an acid tolerance survival response, leading
to physiological changes and enabling survival of a small
subpopulation [33]. Upon entry into the small intestine,
Salmonella are exposed to the destructive effects of the
luminal contents including bile salts, enzymes, antimicrobial
peptides, and secretory IgA [34, 35]. Salmonella have at
least four different infection pathways, namely, via, M-cells,
intestinal epithelial cells, CD18-expressing phagocytes, or
across a damaged intestinal barrier.
Salmonella travel through the mucous layer to invade
intestinal epithelial cells, M-cells, and dendritic cells (DCs).
Intestinal epithelial cells are normally nonphagocytic; how-
ever, Salmonella have the capacity to invade these cells
through a sophisticated machinery termed a type 3 secretion
system (T3SS); the genes encoding the T3SS are located on
Salmonella pathogenicity island 1 (SPI-1) [36, 37]. Salmonella
target specialized M-cells and this initial attachment is
promoted by fimbrae [38]. M-cells sit on top of the lymphoid
follicles of Peyer’s patches which are normally involved in the
pinocytotic sampling of luminal antigens, and this process
plays a key role in mucosal immunity. During the process
of invasion, Salmonella induce membrane ruffles, which
surround the pathogen leading to endocytosis [39]. M-cells
transport Salmonella across the epithelial barrier to DCs,
which play a key role in innate immune responses.
However, following phagocytosis, Salmonella are able to
survive and manipulate the function of the host cell by
using effectors of the SPI-2 T3SS (see below), to interfere
with, for example, antigen processing and presentation [40].
Salmonella are now able to spread systemically by using
DCs as vehicles. Salmonella can also use an alternative strat-
egy to disseminate from the gastrointestinal tract by being
taken up by CD18-expressing phagocytes [41]. These phago-
cytes can transmigrate across tissue barriers and transport
Salmonella from the lumen of the gastrointestinal tract to
the systemic circulation. Salmonella can also disrupt tight
junctions between adjacent epithelial cells, which normally
help prevent leakage of water, ions, nutrients, and immune
cells from the gastrointestinal tract [42].
The Systemic Phase.Once Salmonella break across the epithe-
lial cell barrier they are taken up by intestinal macrophages
and can initiate systemic disease. In the hostile environment
of the phagosome, Salmonella turn on the expression of genes
in another horizontally acquired pathogenicity island termed
SPI-2 T3SS [43, 44]. The resulting gene products modify
the phagosome into a Salmonella containing vacuole (SCV)
and remodel the host cell [45]. Collectively these changes
lead to a more hospitable environment for the survival and
replication of Salmonella. The pathogen can now become
disseminated throughout the reticuloendothelial system. In
most healthy individuals, Salmonella remain localized to the
gastrointestinal tract, which leads to a major migration of
neutrophils into intestinal lumen and results in an inflam-
matory response leading to diarrhea [46]. In most patients
the intestinal infection is limited to the small intestine,
but in a distinct proportion it involves the colon (colitis).
There is a major neutrophil influx into intestinal tissues
during human enterocolitis [46, 47]. Stool samples of these
enterocolitis patients contain leukocytes dominated by the
presence of neutrophils. In otherwise healthy patients, S.
Typhimurium infection is self-limiting leading to clearance
typically within 14 days and does not require antibiotic
treatment [48].
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2.3. Salmonella’s Virulence Machinery Promotes Survival and
Transmission. Salmonella enterica encode a variety of viru-
lence factors to promote survival, replication, and transmis-
sion of the pathogen into new hosts [49, 50]. Of particular
importance to virulence are the type 3 secretion systems
(T3SSs) [51]. These secretion systems enable the pathogen to
directly inject bacterial effector proteins through a molecular
needle-like structure into a host cell to subvert its function.
Salmonella harbor two T3SSs encoded on pathogenicity
islands SPI-1 and SPI-2. Through the innovative work of
Jorge Galan and David Holden and colleagues respectively,
vivid insights have been provided into the importance and
workings of these two elegant systems [37, 52].
TheSPI-1 Type 3 Secretion System Is Important for the Intestinal
Phase of Infections.The SPI-1 system appears to be important
for the intestinal phase of infection, whereas the SPI-2
system is essential for establishing the systemic phase. These
generalized timings for the expression of SPI-1 and SPI-2
genes are now becoming less clearly demarcated [53, 54].
The T3SSs encode for 20 to 30 proteins involved in the
assembly of themacromolecular structure termed the needle-
complex. The proteins can be functionally classed as being
structural, regulatory, chaperones, or effectors of virulence.
The T3SS complex basal body spans both the inner and outer
bacterial membranes and then continues with a narrower
needle complex projecting out from the cell [55]. The SPI-1
T3SS basal body structure is composed of the proteins PrgH,
PrgK, and InvG, and the needle itself is composed of polymers
of a single subunit protein PrgI. This structure resembles
flagella, suggesting an evolutionary connection between these
organelles. This is further supported by the observation that
T3S structural proteins share sequence identity with flagella
proteins [56]. At least three additional proteins are required
for the translocation of effector substrates in to host cells,
namely, SipB, SipC, and SipD. The assembly of the complex
structure takes place through a programmed series of distinct
steps, with similarities again to the flagella assembly pathway.
Once the structure is fully assembled and energized it is now
competent to directly translocate effector substrates in to host
cells from the bacterial cytoplasm, without a periplasmic or
extracellular phase. There are over 13 effector proteins and a
number of which are encoded outside of SPI-1, including SPI-
5 and prophages. These proteins include AvrA, SipA, SipB,
SipC, SipD, SlrP, SopA, SopB, SopD, SopE, SopE2, SptP, and
SspH1, and the list is ever expanding [50, 51, 57]. Indeed SopE
is encoded by a lysogenic bacteriophage [58]. As there is no
direct evidence to support the notion that effector molecules
are transported directly through the needle-complex, a radi-
cally alternative view has been suggested based on data with
Yersinia [59].This model, by HansWolf-Watz and colleagues,
represents a radical shift in our thinking to suggest the
needle-complex may in fact play a role in target cell sensing
and that effector proteins are secreted through a pore in
the host cell membrane [59]. Further, research is needed to
validate these secretionmodels and also it must be noted that
they are not mutually exclusive.
Bacterial Mediated Endocytosis. Key SPI-1 T3SS effector pro-
teins are involved in the process of bacterial-mediated endo-
cytosis, and these include SipA, SipC, SopB, SopE, and SopE2.
In nonphagocytic cells such as intestinal epithelial cells, these
effectors instigate membrane ruffling and engulfment of the
bacteria by the “Trigger” mechanism [60, 61]. Koronakis and
colleagues have observed that many effectors have acquired
multiple functions. For example, SipC is involved in both
actin bundling and also actin nucleation [60, 61]. SipA also
induces actin bundling and polymerization and formation
of the SCV. Furthermore, SipA stimulates neutrophil trans-
migration and remarkably processes and activates caspase-3
[62, 63].
Receptor-Mediated “Zipper” Entry. A variety of independent
experimental approaches have recently provided evidence
which challenges the above established “Trigger” mechanism
paradigm and suggests that invasion of nonphagocytic host
cells by Salmonella can also occur by the “Zipper”mechanism
[64].The Salmonella outermembrane proteins Rck and PagN
appear to function as invasins and promote cell invasion.The
entry mechanism is independent of T3SSs [65].
Induction of Potent Inflammatory Responses. Following inter-
nalization, the Salmonella effectors induce a potent inflam-
matory response. The effectors SopB, SopE, and SopE2
activate the small GTPases Cdc42 and Rac-1, stimulating the
mitogen-activated protein kinase (MAPK) pathway leading
to downstream activation of the transcription factors: activa-
tor protein 1 (AP1) and nuclear factor kappa-B (NF-𝜅B) [66].
AP1 and NF-𝜅B elicit the transcription of proinflammatory
cytokines such as IL8, which stimulates the transmigration
of neutrophils to the intestinal mucosa. SipA alone, as
mentioned above, can also trigger signal cascades leading to
the transmigration of neutrophils into the intestinal lumen
[67]. In addition, SipB has the functionality to activate
the caspase-1 inflammasome leading to increases in levels
of the proinflammatory cytokines IL-1𝛽 and IL-18 [68]. It
has also been observed that SopB, SopE, SopE2, and SipA
can transiently disrupt epithelial cell tight-junctions and
thus disrupt the intestinal barrier, enabling an influx of
neutrophils. Through its inositol phosphatase activity SopB
stimulates chloride ion secretion and ion fluxes [69, 70].
This leads to the characteristic inflammatory diarrhea, an
important feature of gastroenteritis.
The SPI-2 Type 3 Secretion System Is Essential for the Sys-
temic Phase of Infection. Whilst screening for genes essential
for systemic growth of Salmonella in mice, Holden and
colleagues discovered the SPI-2 T3SS using the innovative
technique of signature-tagged mutagenesis [71, 72]. The
SPI-2 T3S apparatus has a very similar structure to the
SPI-1 T3S needle complex. When Salmonella are taken up
or phagocytosed by cells, for example, macrophages, they
develop within the Salmonella containing vacuole (SCV).
The SCV possesses features of a late endosome including an
acidic pH but lacks other characteristic endosome markers
and is therefore considered a distinct entity [52]. It has been
proposed that the main function of the SPI-2 T3SS is to
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modify host cell vesicular trafficking, enabling important
metabolites to be routed to the SCV and thus providing
a safe replication niche. The SPI-2 T3SS genes encoding
the secretion machinery are regulated by two-component
systems, which include OmpR-EnvZ and also SsrA-B located
on SPI-2 itself. The regulatory systems sense the acidic pH
and the weak nutritional environment within the SCV. Once
a translocon pore is assembled in the SCV membrane, the
host cell cytoplasmic pH is sensed, resulting in disassembly
of the regulatory complex composed of SpiC, SsaL, and SsaM
[73]. This triggers the derepression of delivery of around 30
effector proteins.The effector proteins SifA, SopD2, SseJ, and
PipB2 function in the maintenance of the SCV membrane.
The effectors SseF and SseG regulate the SCV’s juxtanuclear
position near the Golgi apparatus. Effectors also target the
host cell cytoskeleton such as SteC, SpvB, SspH2, and SrfH. A
number of effectors including SpvC, SspH1, and SseL play key
roles in ubiquitin modification and host immune signaling
[74].
3. The Microbiota Live in Intimate
Associations with Human Hosts
Complex microbial communities live in intimate associ-
ation with their human hosts in commensal and also
pathogenic interactions. Our understanding of the human
microbiota has been completely revolutionized by the pio-
neering research of Gordon and colleagues [75, 76].The huge
health benefits members of these microbial inhabitants can
provide to their hosts are only just beginning to be fully
realized and can impact upon diverse conditions as allergies,
obesity, diabetes, cancer, and autism. In the sections below
we will discuss the benefits the intestinal microbiota can
provide against invading bacterial enteropathogens such as
Salmonella.
3.1. The Microbiota Is a Large and Diverse Community. A
diverse spectrum of microbial communities live in intimate
associations with their human hosts and are termed the
microbiota [77]. These complex communities contain mem-
bers from all three domains of life, namely, bacteria, archea,
and eukarya. Trillions of bacteria colonize and reside on sur-
faces within and upon us in mainly a symbiotic relationship.
The structure and complexity of these microbial ecosystems
vary depending on their location, for example, from the skin
to the mouth to the intestine. These microbial communities
also provide important ecological benefits to their human
hosts based on their locations. In healthy individuals there is
a balanced relationship with the microbes, with no resulting
disease [75].The numerical importance of themicrobiota can
be gauged if we adopt a metrics system of cell numbers, in
which case humans equate to being only 10% human and
90% microbe [78, 79]. The diverse population of bacteria
that inhabit our bodies is collectively referred to as the
bacterial microbiota, and for the purpose of this review we
will refer to it simply as themicrobiota hereafter.The resident
microbiota is in a state of continual flux and undergoes
changes from birth through to adulthood of their hosts.They
play a key role in maintaining human health by a variety
of mechanisms [80]. The human gastrointestinal tract has a
large surface area of 200m2 and the lumen is rich in nutrients
[81, 82]. Consequently the gastrointestinal tract provides a
very hospitable niche for bacteria. The gastrointestinal tract
contains up to 100 trillion bacteria across approximately 1000
species in humans [82, 83]. However, only a small proportion
of this microbiota can be cultured and the studies have been
reliant on high-throughput sequencing methods to charac-
terize the full range of species present in the microbiota. The
resident microbiota colonizes the length and width of the
gastrointestinal tract, steadily increasing in numbers from
the stomach and duodenum. They vary from as few as 101
bacteria per gram of luminal content in the stomach to 106
bacteria per gram of luminal content in the jejunum and to
as many as 1012 bacteria per gram of luminal content in the
colon (Figure 1). The colonic bacteria are largely facultative
anaerobes and are dominated by the phyla Bacteroidetes and
Firmicutes [80]. Actinobacteria, Proteobacteria, Cyanobacte-
ria, Verrucomicrobia, and Fusobacteria are present as aminor
fraction of microbiota[84].
3.2. The Collective Gene Content of the Intestinal Microbiota Is
Vast and Provides Huge Benefits for the Host. This enormous
community of resident bacteria and their genomes collec-
tively encode the gut “microbiome,” and the microbiome
contains more than 100-fold greater number of genes than
the human host. The microbiome encodes for biochemical
pathways not present in humans which breakdown complex
indigestible polysaccharides and proteins. These pathways
release and generate essential metabolites including amino
acids, vitamins K and B, and short chain fatty acids and
are now metabolically available to the benefit of the host.
These resident bacteria therefore provide huge paybacks
to their hosts. They appear to play key roles promoting
the development of the immune system and promoting
health. The microbiota can also afford the host protection
against invading bacterial pathogens in a process known as
“colonization resistance” and will be discussed later [85].
WeAreWhatWe Eat: Diet Shapes the Composition of the Gas-
trointestinal Microbiota.Diet has a pivotal impact on shaping
the composition of the gastrointestinal microbiota [86]. By
analyzing detailed nutritional intake in 98 adults with the
composition of themicrobiota using 16S rDNA sequencing of
fecal samples, Wu et al. observed that long-term diet shaped
the microbiota enterotypes. For example, intake of animal
fat and protein versus carbohydrates correlated with an
increased association with Bacteroides or Prevotella species,
respectively [86]. Based upon these observations, Turnbaugh
and colleagues investigated the short-term impacts of diet
changes on the plasticity of the gastrointestinal microbiota
using 16S rDNA sequencing [87]. They studied the effects of
dietary regimes based on either animal or plant products and
found that surprisingly even within a single day, the bacterial
community rapidly changed in response to diet [87]. The
animal-based diet led to an increase in bacteria tolerant to
bile such asAlistipes, Bilophila, and Bacteroides. Furthermore,
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Figure 1:Themicrobiota population steadily increases along the length of the gastrointestinal tract from the stomach to the colon.Themajor
resident bacterial phyla/species are indicated, together with the numbers of bacterial cells per gram of luminal contents.
there were reductions in the numbers of Firmicutes, which
metabolize dietary plant polysaccharides including Rose-
buria, Ruminococcus bromii, and Eubacterium rectale [87].
The bacterial gene expression profiles of specific metabolic
modules and pathways also became altered as assessed by
RNA sequencing (RNA-seq).
Temporal Stability of the Gastrointestinal Microbiota. There
has been a major gap in our knowledge on understand-
ing of how the composition of the microbiota changes
throughout the life of an individual. Another landmark
study by Jeff Gordon and colleagues has recently addressed
this issue by examining fecal microbiota in 37 adults [88].
They determined the composition of the microbiota from
these individuals by developing a quantitative low-error 16S
ribosomal RNA amplicon sequencing (LEA-seq)method and
used this in conjunction with whole-genome sequencing.
They observed that 60%of the strains or phylotypes remained
stable for 5 years [88]. This stability followed a power-law
function and could be statistically extrapolated to potentially
remaining stable for decades. In particular Bacteroidetes and
Actinobacteria are significantlymore stable components than
other members of the microbiota. Faith et al. observed that
early gastrointestinal tract colonizingmicrobiota are acquired
from our close family members and can potentially mediate
their biological effects on health for a significant part of their
lives [88].
Antibiotics Impact on the Composition of the Microbiota. The
stability in the composition of the microbiota communi-
ties in humans can be modulated by a variety of factors
including disease, diet, and medicines. For example, the
use of antibiotics in treating infections in humans has a
striking effect on the microbiota with a reduction in various
taxa and a consequent decrease in bacterial diversity [89].
David Relman and colleagues investigated the effects of the
antibiotic ciprofloxacin on the microbiota in three healthy
individuals using deep 16S RNA sequencing. Approximately
one-third of the bacterial taxa in the gut were reduced in
population following antibiotic treatment, and this effect
varied amongst individuals. Furthermore, within 4 weeks the
composition of the community recovered to preantibiotic
treatment levels in all three adults. However, some taxa did
not recover even within 6 months [89]. Thus, antibiotic
treatments can impact upon the diversity of the microbiota
community and as a consequence potentially have longer
term impacts on health and disease in hosts.
Postantibiotic Expansion of Enteric Pathogens. The admin-
istration of oral antibiotics to humans clearly disrupts the
intestinal microbiota and increases the risks associated with
acquiring Salmonella and Clostridium difficile infections. A
very recent study by Sonnenburg and colleagues provided
remarkablemechanistic insights into these observations [90].
These authors used gnotobiotic mice, mono-associated with
the Bacteroides thetaiotaomicron and subsequently infected
with S. Typhimurium. Following recovery of the pathogen
from caecum contents it was subjected to transcriptional
profiling. This analysis revealed that genes involved in car-
bohydrate metabolism were highly upregulated, including
three operons involved in the catabolism of sialic acid, fucose,
and propanediol, a catabolite of fucose [90]. S. Typhimurium
mutants were constructed defective for utilization of sialic
acid and fucose and were found to be significantly less
competitive than the parent strain inmixed infections in vivo.
Compared to germ-free mice, B. thetaiotaomicron colonized
mice contained much greater levels of free sialic acid (N-
acetylneuraminic acid). B. thetaiotaomicron possesses the
enzyme sialidase, which cleaves the terminal sugar from
mucosal conjugates. However, if gnotobiotic mice were col-
onized by a sialidase deficient B. thetaiotaomicron mutant,
this significantly reduced pathogen expansion following
infection. Sialic acid concentrations were next determined
in the ceca of conventional mice following oral antibiotic
treatment and revealed a spike in concentration compared to
untreated mice. However, S. Typhimurium mutants lacking
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the ability to catabolize sialic acid were unable to fuel their
growth in the mouse intestinal tract following antibiotic
treatment. Collectively these data suggest that disruption of
the microbiota modulates carbohydrate availability, which is
exploited by enteric bacterial pathogens to promote growth.
These findings have important therapeutic implications [90].
3.3. Model Systems for Studying Salmonella Infections and
Interactions with the Microbiota. The conventional mouse is
the most common model system used to study S. Typhimu-
rium infection and more recently the interactions with the
microbiota. Mice can be resistant or genetically susceptible
to Salmonella infection. Infection of BALB/c or C57BL/6
mice with S. Typhimurium resembles many aspects of the
infection of humans by the host-restricted S. Typhi, leading
to Typhoid fever. BALB/c or C57BL/6 mice have a mutation
in the gene formerly known as Nramp1 (natural resistance-
associated macrophage protein one) and renamed the Slc11a1
gene that leaves them susceptible to systemic infection by
S. Typhimurium. The mutation results in a defect in the
membrane-bounddivalent cation, that is, the Fe2+ anti-porter
within the Salmonella containing vacuole in macrophages
[91]. The mouse system also offers considerable technical
advantages in the availability of immunological tools and
transgenic knockout mice.
The mouse model can be adapted to study gastroen-
teritis by disrupting the normal microbiota using antibi-
otics [92]. The most popular antibiotic for this purpose is
streptomycin. Streptomycin-treated mice when infected with
S. Typhimurium develop a disease, which resembles more
closely human gastroenteritis, rather than systemic disease.
These mice develop an exudative intestinal inflammation
with migrated neutrophils in the caecum.
On the other hand, gnotobiotic mice contain defined
intestinal microbiota within the gastrointestinal tract and
are an attractive model system to study the impact of
resident intestinalmicrobiota on the process of infection [93].
They can range from abiotic germ-free mice, which have
no microbiota, to monoassociated or polyassociated mice
colonized by known bacterial communities.
The mouse systems have provided excellent models for
studying systemic disease.They have yielded a huge wealth of
information on the biology and pathogenicity of Salmonella
and its interactions with the host and microbiota. However,
the mouse model is of very limited use in studying gastroen-
teritis. Thus, in contrast to mice, natural or experimental
infection of calves with S. Typhimurium leads to a localized
intestinal disease with many of the hallmarks of a human
infection from clinical symptoms to pathology [94]. The
calve model offers many practical and technical challenges,
however, with only a limited set of genetic and immunological
tools, as well as the ethical and financial issues involved.
3.4. The Microbiota Protect the Host from Pathogens by
Providing Colonization Resistance. The gastrointestinal tract
represents a vast mucosal surface area vulnerable to attack by
enteropathogens. The gastrointestinal tract is fortified with
a variety of physical and immunological defence barriers.
A major protective shield for the gastrointestinal tract and
only more recently recognised is the colonising microbiota.
This dense population of microbiota is thought to pro-
vide both a physical barrier for the attachment of bacte-
rial pathogens to the mucosal surfaces and outcompeting
invading pathogens for essential nutrients. This protective
mechanism has been termed “colonization resistance” and
helps prevent invading bacteria under normal conditions
establishing an infection [85].
The streptomycin-mouse model has provided an impor-
tant system to study colonization resistance and colitis follow-
ing S. Typhimurium infection.Oral treatment ofmicewith the
antibiotic streptomycin reduces themicrobiota population by
approximately 80% and reduces the colonization resistance
forwindowof 24 hours or so. If themice are now infectedwith
S. Typhimurium this leads now to very efficient colonization
of the intestine and especially the cecum and colon where
densities as high as 109 colony forming units per gram have
been reported [95]. The microbiota population takes around
36 hours to grow back to original levels.
The microbiota also occupies and blocks the binding of
pathogens to attachment sites present in the mucous layer.
These include carbohydrate groups present within the mucus
layer. Many of the specific receptor-ligand interactions that
take place still remain to be determined. Bacteroides theta-
iotaomicron is an important colonizer of the mucus layer
and digests mucin peptides and O-linked glycans as an
energy source, resulting in the production of short chain
fatty acids (SCFA) such as butyrate [96, 97]. The microbiota
is able to produce a nutritional environment not favorable
for the growth of bacterial pathogens. For example, the
resident microbiota can modify the intestinal composition
of carbohydrates and sugars present, which are essential for
the growth of pathogens [98, 99]. Furthermore, many micro-
biota species such as Bifidobacteria and Lactobacillus are
able to produce organic acids and SCFAs, which are detri-
mental to the growth of bacterial pathogens such as S.
Typhimurium [100–102]. The microbiota, and in particular
members of the Clostridium clusters IV and XIVa, now also
known as Ruminococcaceae and Lachnospiraceae, produce
the SCFA butyrate as a metabolite [103, 104]. Butyrate is an
“antivirulence molecule” which acts as a diffusible signal to
downregulate expression of the SPI-1 T3SS invasion genes in
Salmonella [103, 105]. In contrast the SCFA formate induces
the expression of the SPI-T3SS and invasion [106].The SCFAs
formate and acetate are largely located within the small
intestine, whereas butyrate and propionate predominate in
the colon [107].
3.5. Pathogen Clearance: The Microbiota and sIgA Have
Complementary Protective Functions. It has been observed
that following a Salmonella infection some individuals con-
tinue to shed Salmonella in stools once they have become
asymptomatic [108]. These asymptomatic excretors are a
major transmission risk. To investigate this phenomenon,
Baumler and colleagues extended the coverage time of the
streptomycin-mouse model to encompass later stages of
infection when intestinal mucosal inflammation has begun
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to decline [109]. As discussed later in this review when
the mammalian gastrointestinal tract becomes infected with
Salmonella, there is an outgrowth of the pathogen at the
expense of the resident microbiota, leading to a substantial
reduction in its population size. Following an episode of such
an acute infection and decreasing inflammation, pathogen
clearance steadily reverses this process by reducing the lumi-
nal pathogen load and allowing themicrobiota to regrow.This
eventually leads to restoration of microbiota composition
and numbers to steady-state levels. The mechanistic basis of
pathogen clearance remains to be elucidated and conceivably
may be multifactorial. For example, it is possible that the
microbiota may generate inhibitory molecules or stimulate
immunity. The gastrointestinal tract barrier function may
also stabilize. An adaptive secretory IgA (sIgA) response
is elicited during the later stages of infection and does
not appear to play a significant role during this phase of
clearance. However, if mice encounter this pathogen again,
sIgA specific for S. Typhimurium LPS O-antigen appears
to prevent inflammation. Hence, the microbiota and sIgA
work in synchrony to protect against pathogens. This is
evidently an important area of future research and undoubt-
edly will have important implications for other pathogens
[110]. Nevertheless, host resistance to colonization can be
manipulated by successful bacterial pathogens. There have
been significant insights into our understanding of the inge-
nious counter-mechanisms employed by enteropathogens to
bridge these lines of defence. These are discussed in later
sections.
3.6. Salmonella Can Exploit the Hydrogen Produced by
the Resident Microbiota to Jump-Start Initial Growth. In a
normal healthy gastrointestinal tract, the resident micro-
biota generates hydrogen as a central chemical intermediate
of metabolism. Wolf-Dietrich Hardt and colleagues have
screened for essential genes required during infection in
vivo using a transposon mutant bank [111]. Remarkably they
identified hyb hydrogenase as playing a key role during the
initial growth phases of Salmonella infection, and the findings
were validated by a variety of methods including competitive
infection experiments. Compelling evidence provided by the
authors suggest that during these initial phases of infection,
Salmonella can harvest or “steal” the hydrogen produced by
the resident microbiota to “jump-start” and fuel their growth
bloom [111].
4. Salmonella Fires Up Mucosal Inflammation
in the Gastrointestinal Tract
Enteric pathogens, such as Salmonella, have devised strategies
to unlock colonization resistance, compete with microbiota,
and successfully infect the host. Vivid insights into the strate-
gies deployed by Salmonella to compete with the resident
microbiota have been provided by landmark studies from the
laboratories of Andreas Baumler and Wolf-Dietrich Hardt,
and colleagues [112, 113]. These studies and their remarkable
findings are discussed in the sections below.
4.1. Inflammation Unlocks Colonization Resistance. In the
mouse colitis model Wolf-Dietrich Hardt and colleagues
observed that the potent inflammatory responses elicited
by wild-type S. Typhimurium provided the pathogen with
a major competitive growth advantage. This leads to a
reduction in the population size of the microbiota and
its composition and hence dysbiosis (Figure 2) [114, 115].
Surprisingly an avirulent S. Typhimurium invG, sseDmutant
with disruptions in the SPI-1 and SPI-2 T3S systems failed
to induce an inflammatory response and the mutant was
unable to compete with themicrobiota. However, thismutant
phenotype could be rescued by inducing inflammation either
by coinfection with the wild-type strain or using a trans-
genic strain of mice IL10−/−, VILLIN-HACL4-CD8, designed
to mimic the inflammatory state in irritable bowel disease.
Hence, inflammation is key to surmounting colonization
resistance. Thus, inflammation can in some instances benefit
the pathogen at the expense of the host and microbiota [115].
4.2. Mucosal Inflammation Generates Exclusive Terminal
Electron Acceptors for Respiration. S. Typhimurium is able
to infect intestinal epithelial cells and survive within the
hostile environment of professional macrophages. This is
possible because Salmonella harbor the SPI-1 and SPI-2 T3SS
that enable them to invade and survive within these cell-
types. The effector proteins from these secretion systems,
for example, SopE, are translocated into host cells to elicit
the production of proinflammatory cytokines and potent
inflammatory responses [116]. The inflammatory responses
are amplified by T-cells located in the intestinal mucosa and
release important cytokines.
It has been observed that during S. Typhimurium infec-
tions, neutrophils transmigrate in to the intestinal lumen and
release reactive oxygen species (ROS) to destroy invading
pathogens [117]. The strictly anaerobic Bacteriodetes are
dependent on complex polysaccharides and amino acids for
fermentation and energy generation [96]. An end product of
this fermentation is highly toxic hydrogen sulfide (H
2
S).This
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−2; Figure 3) [118]. Andreas Baumler
and colleagues have vividly demonstrated that the major-
ity of the microbiota species are unable to biochemically
use tetrathionate, but remarkably S. Typhimurium is able
to exploit tetrathionate as a terminal electron acceptor in
anaerobic respiration (Figure 3) [118].
Several decades ago a multidrug resistance S. Typhim-
urium emerged which contained the SopE virulence gene
within a prophage. SopE encodes for a SPI-1 T3S effector
protein, which stimulates immune signaling pathways and
also inflammation of the gastrointestinal tract [116, 119].
The prophage also enhanced the fitness of the strain by
unknown mechanisms, and so its role in the mouse colitis
model was examined. Baumler and colleagues found that
SopE triggers the host to inadvertently generate nitrate, a
thermodynamicallymore efficient terminal electron acceptor
than tetrathionate [58, 120]. In the mouse colitis model they













Figure 2: Salmonella are able to elicit host inflammation to ultimately inverse the intestinal bacterial population pyramid and become the
dominant species. The intestinal microbiota exists in a delicate balance within the healthy host. An invading enteropathogen, such as S.
Typhimurium, disturbs this balance by its interactions with the host and residentmicrobiota. S.Typhimurium type 3 secretion effector proteins
trigger the release of cytokines and inflammation. This leads to a growth burst of S. Typhimurium, at the expense of the resident microbiota
resulting in inversion of the bacterial population pyramid and dysbiosis.
observed that there was an increase in mucosal inducible
nitric oxide synthetase (iNOS) production following an S.
Typhimurium infection. iNOS generates NO which in the
presence of ROS forms peroxynitrite (ONOO−). Subse-
quently, peroxynitrite isomerizes to nitrate (NO
3
−), a termi-
nal electron acceptor that can promote the luminal growth
of S. Typhimurium by anaerobic respiration (Figure 3). This
nitrate respiration-dependent growth advantage was reduced
in iNOS-deficient mice [58]. Interestingly, nitrate also sup-
presses the expression of bacterial genes involved in the
utilization of tetrathionate. This hierarchical control ensures
the most energetically efficient electron acceptor is used in
the competitive environment of the large intestine. Nitrate
thus fuels growth blooms of S. Typhimurium in the inflamed
intestine [58, 120].
Thus, the utilization of nitrate or tetrathionate as terminal
electron acceptors in respiration is a farmore efficient process
for energy generation than fermentation. This provides a
potentially huge competitive advantage to S. Typhimurium
over the resident microbiota and allows the pathogen to
access new carbon sources.
4.3. Terminal Electron Acceptors Enable Salmonella to Uti-
lize Unique Substrates for Fermentative Growth Leading to
Blooms. The gastrointestinal tractprovides an environment
rich in diverse nutrients but the substrates able to sup-
port fermentative growth in the anaerobic environment are
limited. The situation is exacerbated during inflammatory
diarrhea where the rich contents of the gut are rapidly
flushed out of the body and no longer available. In the
inflamed gastrointestinal tract nutrients may become lim-
ited to mucous-derived carbohydrates and the contents of
damaged intestinal epithelial cells such as the membrane
lipid, phosphatidylcholine. In fact phosphatidylcholine can
be readily metabolized to ethanolamine in mammalian
intestines. Indeed in calve intestines ethanolamine is readily
observed at a concentration of approximately 2mM [121].
Baumler and colleagues have investigated the ability of S.
Typhimurium to utilize ethanolamine [122]. They observed
in vitro that ethanolamine could support the growth of
S. Typhimurium only in the presence of tetrathionate. To
investigate this in vivo, the mouse colitis model was used
where mice were treated with streptomycin to disrupt the
normal microbiota and then orally infected with a panel of
S. Typhimurium mutants including those unable to induce
inflammation, for example, SPI-1 and SPI-2 T3S mutants,
ethanolamine utilization (eutC), and tetrathionate reductase
(ttrA). Through a series of experiments they concluded that
in the inflamed gastrointestinal tract, S. Typhimurium is able
to use tetrathionate respiration to consume ethanolamine
as a nutrient [122]. Ethanolamine cannot be used by the
majority of the bacteria in the gut and thus confers S.
Typhimurium with a huge growth advantage, which it indeed
exploits. The resulting growth bloom in the gastrointestinal
tract enhances transmission. Thus, Salmonella has used an
ingenious mechanism to trigger inflammation to its benefit
but detrimental to the host and competing microbiota.
4.4. Chemotaxis and Flagella-Mediated Motility Enables Sal-
monella to Identify and Swim to Nutritionally Beneficial
Niches. Recent findings using a panel of mutant strains
suggest that chemotaxis is important for growth of Salmonella
in the inflamed intestinal tract and is dependent on
flagella-mediated motility. These attributes may enable S.
Typhimurium to migrate to suitable nutritional environ-
ments to maximize growth potential. Using chemotaxis,
S. Typhimurium senses sugars such as galactose, which is
present in high concentrations within the cecal mucosa, and
these potential substrates may provide a chemotactic signal.
However, the signals are also present in the noninflamed
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Figure 3: Salmonella use a variety of elegant strategies to competewith the intestinalmicrobiota. During the early stages of intestinal infection,
Salmonella are able to scavenge the hydrogen produced by the microbiota to fuel initial growth. Microbiota produced short chain fatty
acids (SCFAs) can modulate the expression of Salmonella SPI-1 invasion genes both positively (formate) and negatively (butyrate). Using
the SPI-1 and SPI-2 type 3 secretion systems, S. Typhimurium are not only able to promote invasion and survival within host cells but also
able to strategically elicit a host inflammatory response, which ultimately benefits the pathogen. The microbiota produces hydrogen sulfide,
which normally becomes detoxified by host cells to thiosulfate. An inflammatory response leads to the transmigration of neutrophils into
the intestinal lumen and the subsequent release of reactive oxygen species (ROS). When thiosulfate is exposed to ROS it is oxidized to
tetrathionate, which can be exclusively used by S. Typhimurium as an alternative electron acceptor. S. Typhimurium can now utilize alternative
carbon sources from the host, such as ethanolamine, using tetrathionate in anaerobic respiration. The inflammatory response results in the
release of cytokines such as interferon-gamma (IFN𝛾). This results in the induction of expression of inducible nitric oxide synthase (iNOS),
which generates nitric oxide. Upon exposure to superoxide free radicals nitric oxide is generated, and when exposed to ROS nitric oxide
is converted to peroxynitrite and then nitrate. Nitrate can be used exclusively by 𝑆. Typhimurium, as an alternative electron acceptor during
anaerobic respiration.This leads to an enormous growth burst in the pathogen leading to dysbiosis. Nitrate is thermodynamically the preferred
electron acceptor over tetrathionate.
gastrointestinal tract, so what is the nature of the in vivo
signal in the inflamed gut? To answer this question, Rivera-
Chavez et al constructed a series of mutations in the methyl
accepting chemotaxis proteins and the strains examined in
the mouse colitis model [123]. The methyl accepting chemo-
taxis proteins Aer and Tsr were observed to enhance fitness
by chemotaxis towards electron acceptors tetrathionate or
nitrate, respectively, when these were required to provide
a growth advantage in vivo. Thus, the methyl accepting
chemotaxis proteins clearly enable the pathogen to “taste”
their way to a nutritionally favorable niche and facilitate
growth blooms [123].
4.5. The Gastrointestinal Tract Provides an Environment Con-
ducive to Horizontal Gene Transfer amongst Residents. The
entire coding capacity of the microbiota is referred to as the
gene pool or “microbiome.” The microbiome can become
altered by a variety of factors that affect the abundance of
bacterial species. Asmentioned previously these factors range
from dietary changes, the use of antibiotics, and disease states
to the acquisition of new species including pathogens. The
resident species can acquire subtle genetic changes by natural
point mutations or by the “brute force” of horizontal gene
transfer (HGT) [124]. The latter processes enable species to
acquire entire blocks of genes, for example, those involved in
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metabolism, antibiotic resistance, or encoding new virulence
factors. Thus, HGT enables the species to evolve at a rapid
rate in contrast to the slow accumulation of random point
mutations. HGT takes place most efficiently between closely
related species, for example, between Enterobacteriaceae.
Furthermore, there is strong genomic evidence to suggest
that HGT has taken place within the intestinal microbiota
[125]. For example, it has been suggested that resistance
to bile conferred by a bile salt hydrolase (bsh) present in
Bacteroides, Bifidobacterium, Clostridium, Lactobacillus, and
Enterococcus may have been acquired by HGT [126]. Under
appropriate conditions HGT can also be observed between
Enterobacteriaceae and Gram-positives and profoundly even
across kingdoms [127–129]. Mechanistically, HGT can take
place by transformation, transduction, and conjugation.
DNA Transformation. The uptake of released DNA from
“donor” cells in the environment and its stable incorporation
and expression within the recipient cells leads to DNA
transformation. The ability of recipient strains to take up
DNA and recombine it within their genomes is referred to
as competence. Transformation in the gastrointestinal tract
is expected to be infrequent due to the conditions, which
do not favor the survival of free naked DNA. However, it
has been suggested that stresses in the gastrointestinal tract
may promote competence [130]. Indeed environmental cues
such as the presence of chitin have been shown to induce the
natural competence of Vibrio cholerae [124].
Phage Transduction. The DNA of host bacterial cells can
be encapsulated by phages and transferred horizontally to
recipient bacterial cells, in a process referred to as phage
transduction. To promote their own survival within bacteria,
phages have acquired additional genes not necessary for
their lifecycle but provide a selective advantage for the host
bacterium when the phage has integrated into the bacterial
genome and is now a prophage.These fitness genes are known
as “morons” and make the bacterium more competitive in
the intestinal environment. Phages are physically resilient
structures, which are expected to survive effectively in the
milieu of the gastrointestinal tract. Transduction has clearly
been an important mechanism for the transmission of genes
as evidenced by genome sequencing where it has been
uncovered that many virulence factors in enteropathogens
are encoded by prophages. For example, in S. Typhimurium
it has been observed that the T3S effector protein SopE is
encoded by a prophage [131]. Strikingly there is new evidence
to suggest that the acquisition of SopE by HGT stimulates the
host to produce the electron acceptor nitrate to fuel a growth
bloom of S. Typhimurium in the gastrointestinal tract [58].
Further in the Gram-positive Enterococcus faecalis, a facul-
tative anaerobe and commensal of the human gastrointesti-
nal tract, the acquisition of a composite prophage boosted
the fitness of E. faecalis both in vitro and in vivo within
the mammalian intestine [132]. These observations suggest
that prophages associated with intestinal bacteria have a
significant impact in shaping the bacterial communities in the
gastrointestinal tract.
Plasmid Conjugation. Direct physical contact between donor
and recipient bacteria are required for conjugative transfer
of DNA. Conjugative plasmids are transferred to recipient
cells through a conjugative pilus encoded by the plasmid.
Not surprisingly conjugation efficiency increases with higher
cell densities for the donor and recipient cells enabling more
conjugative events to take place. As bacterial cell densities
are very high within the gut, this niche will provide an
environment perfect for promoting conjugative exchange of
DNA. These exchanges are facilitated by the optimal growth
conditions provided by an influx of nutrients within the
gastrointestinal tract and a constant temperature of 37∘C.
Norepinephrine CanModulate HGT.Thecatecholamine nore-
pinephrine is produced within the gastrointestinal tract,
and it has been observed in vitro that norepinephrine, at
physiological concentrations, promotes conjugative transfer
of a large multidrug resistance plasmid from a clinical strain
of S. Typhimurium to an E. coli recipient [133]. Furthermore,
this effect appeared to be inhibited by the exposure of the
cells to the 𝛼-adrenergic receptor antagonist phentolamine.
The role of catecholamines in interkingdom signaling will be
discussed in a later section.
Inflammation Triggers Bacterial Growth Blooms Which Pro-
motes HGT. A major factor in promoting HGT is inflam-
mation within the gastrointestinal tract leading to very
high densities of Enterobacteriaceae [134]. Enterobacteri-
aceae are normally present in the gastrointestinal tract at
low cell densities (<108 cells/mL). Growth blooms in these
bacteria can occur due to inflammation caused by invading
pathogens such as Salmonella, as discussed already [115].
These blooms are fuelled by the increased availability of high-
energy nutrients, which can be used by Enterobacteriaceae
or the pathogens but not the resident microbiota. In some
elegant studies by Hardt and colleagues it was demonstrated
that when mice become infected with S. Typhimurium, the
resulting inflammatory responses leads to growth blooms of
the pathogen. Furthermore, the residentE. coli are also able to
benefit from the products of these inflammatory responses.
This results in a rapid elevation in enterobacterial numbers
by several orders of magnitude leading to dysbiosis [134].
The increased density of the Enterobacteriaceae facilitates
elevated physical contact, resulting in prolific conjugative
rates from S. Typhimurium to E. coli of a conjugative plasmid
encoding the bacteriocin colicin 1b. Thus, inflammation
clearly promotes HGT between closely related bacteria.
Interestingly, Stecher and colleagues have recently dem-
onstrated that within enterobacterial blooms, colicin Ib-
mediated killing of competing commensal E. coli confers
a distinct growth advantage to S. Typhimurium [135]. The
genes encoding colicin Ib (colIb) and its receptor CirA were
upregulated in S. Typhimurium and E. coli, respectively, dur-
ing inflammation [135]. The mosaic genome of Salmonella,
containing pathogenicity islands, prophages, transposons,
and plasmids, provides evidence for significant levels of HGT
during the evolution of this pathogen [11, 18, 136]. Further-
more, in a clinical setting, HGT in the inflamed gut may
promote the spread of antibiotic resistance genes between
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the microbiota and invading pathogens and subsequently
selected by antibiotic therapy.
4.6. Host Toll-Like Receptor Sensing of Salmonella Activates the
Bacterial Virulence Machinery. The innate immune system
plays a vital role in controlling infections once a pathogen has
been detected. The system recognizes pathogen-associated
molecular patterns (PAMPs) and sets in to play a series of sig-
naling cascades designed to eliminate the pathogen and warn
the adaptive immune system of infection [137–139]. PAMPs
are recognized by a special family of proteins called toll-
like receptors (TLRs). When triggered, TLRs recruit host cell
adaptor proteins including MyD88 and TRIF, which activate
signaling cascades to promote defense of the host. Each TLR
recognizes a particular signature; for example, TLR-4 recog-
nizes lipopolysaccharide from the outermembranes ofGram-
negative bacteria, whereas TLR-5 detects bacterial flagellin
[140]. TLRs are distributed on the surfaces of many cell-types
including macrophages and mucosal epithelial cells.
As discussed earlier Salmonella reside and replicate
within host cells such as macrophages by transforming the
hostile environment of the phagosome into the Salmonella-
containing vacuole. They survive these harsh conditions by
turning on the expression of SPI-2 T3SS genes. The T3S
effectors enable the pathogen to manipulate the environment
of the host cell for its benefit. What are the signals, which
turn on expression of the SPI-2 T3SS? Holden and colleagues
demonstrated through some elegant studies that expression
of SPI-2 T3S is triggered by acidic pH [73]. Using a panel
of transgenic TLR knock-out mice, Arpaia et al. have shown
that acidification of the phagosome is in fact activated by TLR
signaling which rather than protecting the host actually now
benefits the pathogen [139].
4.7. Extinguishing Inflammation in the Gastrointestinal Tract:
Hypoarginemia Elevates Susceptibility to Salmonella Infection.
The gastrointestinal tract is one of the most metabolically
active tissues in humans and has high levels of protein
synthesis and cell turnover. Regulation of the gut barrier
function is crucial for preventing disease and maintaining
good health. The amino acid L-arginine (L-Arg) is not only
required for protein synthesis but also appears to be impor-
tant as a regulator of intestinal function and homeostasis.
Indeed the availability of extracellular arginine can impact
upon immune defense [141]. This is because arginine is
a substrate for inducible nitric oxide synthetase iNOS to
generate nitric oxide. Nitric oxide is an effective antimicrobial
agent produced by macrophages to combat pathogens but as
discussed in this review, nitric oxide can also be exploited
by Salmonella through its inflammatory response and used
to generate nitrate, which can subsequently be used as a
terminal electron acceptor (Figure 3) [58]. Recently it has
been observed that malaria-patients develop L-arginine defi-
ciency which reduces intestinal barrier function and makes
the patients vulnerable to coinfection with S. Typhimurium
[142]. These effects can be compensated by supplementing
the diet of patients with arginine, which leads ultimately to
improved intestinal barrier function and protection against
infection by S. Typhimurium [143].
5. Salmonella Show Their Metal under Fire
To successfully compete against the resident microbiota
within the inflamed gastrointestinal tract, Salmonella must
acquire vital nutrients. Some of these nutrients includemetals
such as iron, zinc, copper and are essential for growth and
proliferation [144, 145].
5.1. Salmonella Can Defend against the Effects of Antimi-
crobial Peptides and Sequester Precious Metals. Within the
gastrointestinal tract, pathogens are under attack from host
antimicrobial peptides such as lipocalin-2, which are secreted
by the intestinal epithelial cells and protect against invading
bacteria [146]. Intestinal infections with S. Typhimurium lead
to an increase in IL-17 and IL-22 production, which in turn
stimulate the intestinal cell production of lipocalin-2, which
subsequently accumulates in the lumen. Iron is an essential
metal required by bacteria including S. Typhimurium. To
scavenge for iron, bacteria can secrete siderophores, such
as enterochelin, which bind any available iron in the envi-
ronment and are subsequently taken up by the bacterial
cell. Lipocalin-2 is a 24 kDa glycoprotein which binds to
bacterial siderophores, thus starving bacteria of essential iron
and preventing growth [147]. However, S. Typhimurium are
resistant to the effects of lipocalin-2 as they are able to
synthesize an alternative iron binding protein salmochelin.
The synthesis and uptake system for salmochelin are encoded
by the iroBCDE and iroN genes [148–153]. Salmochelin is a
glycosylated derivative of enterochelin, which does not bind
lipocalin-2 and is thus resistant to its effects. This resistance
provides S. Typhimuriumwith a significant growth advantage
against competing bacteria in the inflamed intestine [146].
Bacterial pathogens also face a barrage of attack from
neutrophils, which have migrated into the intestinal lumen.
Approximately 40% of the cytoplasmic nutrient content of
neutrophils is composed of a protein named calprotectin
[117]. Calprotectin has potent antimicrobial activity against
many bacterial pathogens including E. coli and Listeriamono-
cytogenes, due to its ability to bind and sequester essential
metals such as zinc and manganese. Raffatellu and col-
leagues observed that in the presence of S. Typhimurim, neu-
trophils are induced to release calprotectin [154]. However, S.
Typhimurium is able to survive the effects of calpoprotectin
by expressing a high affinity zinc transporter (ZnuABC).This
transporter enables the pathogen to grab zinc and provides
a growth advantage over the competing bacteria in the
inflamed environment of the gastrointestinal tract.
5.2. Probiotic Bacteria Pump Iron to Raise Fitness and Out-
compete Salmonella. Probiotics are commensal organisms
that provide benefits to the host by direct interactions or by
competition with pathogens as discussed above in coloniza-
tion resistance. During an outbreak of shigellosis, a probiotic
strain was isolated from a soldier who appeared resistant
to an outbreak of diarrhea [155]. The probiotic strain was
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Escherichia coli Nissle 1917 (serotype O6:K5:H1). The E. coli
Nissle strain colonizes the gastrointestinal tract efficiently and
has been successfully used as a probiotic for treating intestinal
disorders by unknown mechanisms [156]. As acquisition of
nutrients such as iron are important for S. Typhimurium,
the genome of E. coli Nissle was examined and revealed
the presence of multiple iron uptake systems. These include
salmochelin, the mixed-type siderophore yersiniabactin, the
hydroxamate-type siderophore aerobactin, and the hemin
uptake transporter ChuA [157]. Rafettellu and colleagues
hypothesized that iron uptake mechanisms are vital for
E. coli Nissle probiotic activity. Using the S. Typhimurium
colitis mouse models the investigators observed that this
nonpathogenic E. coli Nissle was able to outcompete and
reduce the size of S. Typhimurium populations during mixed
infections. However, when an iron uptake mutant of E. coli
Nissle was examined it was found to colonize the intestinal
tract but was now unable to dampen down the S. Typhimurim
population size [157]. Using the mouse models to examine
the impact in further detail, it was observed that iron plays
an essential role in promoting the competitiveness of E. coli
Nissle in a lipoclain-2 system [157]. The inoculation of E.
coli Nissle resulted in a massive reduction in colonization of
S. Typhimurium and a general reduction in gastrointestinal
inflammation. This study has provided valuable insights in
to the mode of action of probiotics, and these organisms
could be further developed to provide important benefits to
a variety of intestinal diseases.
6. Multidirectional Chemical Signaling within
the Gastrointestinal Tract
The gastrointestinal tract contains a highly complex com-
munity of host cells, microbiota, together with invad-
ing pathogens. These diverse cellular communities provide
remarkable opportunities for signaling at multiple levels
between the resident microbiota and host cells, together with
invading pathogens. Understanding the mechanistic basis of
multidirectional chemical signaling will provide important
insights into health and disease. These signaling processes
may operate at the levels of quorum sensing or interkingdom
communication (Figure 4).
6.1. Quorum Sensing with Bacterial Autoinducers. Bacteria
synthesize small diffusible signal molecules to count and
monitor their population density by a process termed “quo-
rum sensing” [158, 159]. When a critical concentration of this
signal molecule is reached, this information is relayed and
used to coordinate gene expression within the population
and modulate the expression of important phenotypes such
as virulence, biofilm formation, and persistence [160]. The
bacterially produced signaling molecules are referred to as
autoinducers AIs and these molecules are generally very
similar in related species [161]. There is now also increas-
ing evidence to suggest that these AIs can also be sensed
by species which do not produce the signals themselves,
leading to interspecies signaling. These AIs could thus have
a major impact on the composition and development of
polymicrobial communities in natural settings such as in the
environment or a host (Figure 4) [162, 163].
Acyl-homoserine Lactone: An Enteric Signal. Many Gram-
negative bacteria, with the notable exceptions of E. coli and
Salmonella, quorum sense with N-acyl-homoserine lactone
signaling molecule [acyl-HSL] also known as autoinducer-
1 [AI-1] [158]. LuxI synthesizes the QS signal molecule,
which is subsequently detected by the cognate sensor and
transcriptional regulator LuxR. Acyl-HSL can vary in their
acyl side chain length from 4 to 18 carbons. Although neither
E. coli nor Salmonella synthesize acyl-HSL, they do possess
a LuxR orthologue known as SdiA. Consequently they can
sense acyl-HSLs produced by other bacterial species in a
process aptly termed “eavesdropping” [164]. These enterics
can infect the intestinal tracts of humans and animals and
it maybe that Salmonella and E. coli are able to detect acyl-
HSLs produced by members of the intestinal microbiota
and use these signals as an environmental cue to regulate
gene expression. Barring physical degradation of the acyl-
HSLs, there appears to be no chemical or biological evidence
to support this notion. However, Ahmer and colleagues
used a clever genetic screen, a recombination-based in vivo
expression technology (RIVET) reporter system, in which
SdiA dependent detection of acyl-HSLs would result in a
permanent deletion of a tetracycline resistance gene during
the passage of Salmonella through a host [164–167]. The
Salmonella infection reporter screen did not detect any acyl-
HSL during infections of a number of animals ranging from
mice to chickens to cows. However, the reporter was found
to become active in turtles and also in mice, which had been
infected with the pathogen Yersinia enterocolitica [165].Thus,
it appears that the intestinal microbiota does not appear to
produce detectable levels of acyl-HSLs, but some intestinal
pathogens can generate acyl-HSLs enabling S. Typhimurium
to eavesdrop on these quorum sensing pathogens when
coinfecting the host.The competitive advantages of acyl-HSL
eavesdropping for Salmonella remain to be elucidated.
The “Universal” Signal Autoinducer 2. The majority of
both Gram-negative and Gram-positive bacteria possess the
enzyme LuxS that is an AI-2 synthase or S-ribosyl homo-
cysteine lyase, including members of the intestinal micro-
biota such as Bacteroides species. AI-2 is believed to be
a QS signaling molecule, which has been referred to as
a universal signaling molecule due to the widespread dis-
tribution of luxS [161]. In the well-studied Vibrio harveyi
system, AI-2 is a furanosyl borate diester. In contrast to
S. Typhimurium, AI-2 has the identity of (2R,4S)-2-methyl-
2,3,3,4-tetrahydroxytetrahydrofuran (R-THMF) and lacks
boron [168]. The role of AI-2 as a true QS signaling molecule
remains to be unequivocally demonstrated in most cases
[163, 169, 170]. In bacterial species studied to date AI-2/luxS
appears to regulate expression of genes involved in virulence,
biofilm formation, motility, and carbohydrate metabolism.
In S. Typhimurium, AI-2 affects the expression of the AI-2
uptake system the Lsr operon [171–173]. However, LuxS plays
an importantmetabolic role in the activatedmethyl cycle, and
its role in metabolism could have an impact on the observed






AI-1, 2, 3, indole
AI-2, 3
AI-1, 2, 3, indole
AI-2, 3
AI-1, 2, 3, 
indole NorepinephrineNorepinephrine AI-2, 3
Figure 4: Chemical signaling between Salmonella, the intestinal microbiota, and the host. In the complex environment of the gastrointestinal
tract there are opportunities for chemical signaling to take place between the microbiota, host cells, and the invading pathogen. The resident
microbiota and S. Typhimurium may produce signaling molecules, which modulate the activities of the microbiota or pathogen. Examples
of such signaling molecules include AI-1, AI-2, AI-3, and indole. Some of these signals may also modulate the activities of host cells such as
AI-1, AI-3, and indole. The host can produce signaling molecules, which can also be detected by the microbiota and pathogens to modulate
their activities. These host signals include catecholamine hormones such as norepinephrine.
phenotypes. This is supported by the following observations.
In S. Typhimurium it has been demonstrated that a luxS
gene deletion mutant modulates flagellar phase variation
independent of AI-2 leading to expression of phase-1 flagellin
subunits [174, 175]. Complementation studies revealed this
phenotype appeared to be dependent on the small RNAmicA
located immediately upstream to the luxS coding sequence
rather than the luxS gene product itself [174, 176]. The same
observation is true for Salmonella biofilm formation [175].
Furthermore, in Streptococcus sanguinis, complementation
of the active methyl cycle with the S-adenosylhomocysteine
hydrolase (SahH) gene restores biofilm formation indepen-
dently of AI-2 and luxS [177]. The picture is also complicated
as the luxS deletion mutant also has pleiotropic effects on
S. Typhimurium gene expression [178]. As a consequence
of the pleiotropic effects on bacterial metabolism, AI-2 has
also been indirectly implicated in the production of another
autoinducer (AI-3) in E. coli and also Salmonella [179, 180].
It has recently been demonstrated thatBacteroides species
can produce AI-2 like molecules [181], and heterologous
expression of Bacteroides luxS orthologues can comple-
ment AI-2 production in E. coli [182]. As members of the
intestinal microbiota produce AI-2, it is not inconceivable
that members of these dense communities exploit LuxS-
based signaling to modulate gene expression and community
phenotypes.
Commensal Bacterial Indole Signals Diminishes the Path-
ogenicity of Salmonella. There is increasing evidence to
suggest that indole signaling is used by bacteria within the
gastrointestinal tract for communication [183]. In commensal
E. coli the environmental conditions of the intestine induce
the expression of tryptophanase (tnaA), the enzyme that
generates indole. Indole concentrations in the mammalian
intestine can vary from 250𝜇M to 1mM [184].
Indole is produced by E. coli in stationary phase cells and
appears to regulate biofilm formation, acid resistance, and the
locus for enterocyte effacement in pathogenic E. coli [185].
Indole also elevates the expression ofmultidrug exporters and
has an impact on population based antibiotic resistance in E.
coli. Indole signaling clearly affects membrane and oxidative
stress response. Following on from this it has been demon-
strated that indole induces the formation of persisters, where
a fraction of the isogenic bacteria in a population “tolerate”
antibiotics. Persister formationwasmonitored by Collins and
colleagues by the novel use of microfluidics, combined with
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fluorescence microscopy and DNAmicroarray screens [186].
They identified stress response pathways, includingOxyR and
phage stress response (Psp), which were essential for persister
formation. Thus, E. coli can use a “bet-hedging” strategy
when nutrients are limited by producing a heterogeneous
population of bacteria to improve their chances of survival
[186].
Curiously S. Typhimurium is unable to produce indole
as it does not have the tryptophanase enzyme. However,
indole has been observed to induce the expression of the S.
Typhimurium acrAB-tolC multidrug efflux system and this
phenotype is dependent upon the regulator RamA. Intrigu-
ingly using DNA microarrays the authors observed that
indole downregulated the expression of the SPI-1 T3SS genes
and also genes involved in motility [185]. These changes were
directlymanifested phenotypically by a reduction in invasive-
ness andmotility.These phenotypes as discussed elsewhere in
this review are clearly important for eliciting an inflammatory
response in the host and benefits Salmonella competitively
at a nutritional level over competing microbiota, including
commensal E. coli, leading to growth blooms. Thus, this may
be a mechanism designed by members of the microbiota to
dampen the competitiveness of S. Typhimurium and reduce
the growth blooms.This suggests that indole could potentially
be used therapeutically to control infections against bacterial
pathogens such as S. Typhimurium.
Intestinal Cells Can Intercept Bacterially Produced Indole to
Fortify Host Defense Barriers. From the previous sections
there is convincing evidence to suggest interkingdom com-
munication can take place by bacteria eavesdropping on host
signaling molecules such as hormones (Figure 4). Bacteria
also exploit indole as a signaling molecule as discussed. The
physiological impact of bacterially produced indole on host
intestinal cells was investigated by Jayaraman and colleagues
[187]. They observed changes in gene expression in the
human enterocyte HCT-8 cell line when exposed to phys-
iological concentrations of indole using DNA microarrays
and phenotypic screens. They observed that indole increased
expression of anti-inflammatory genes and the downregu-
lation of some proinflammatory genes. Furthermore, genes
involved in enhancing the mucosal barrier such as actin-
cytoskeleton and tight-junction proteins were elevated, with
increases in mucin gene expression and production. This led
to an increase in the transepithelial cell resistance of theHCT-
8 cells suggesting themucosal barrier had been fortified [187].
This reduces the ability for enteric pathogens to traverse the
intestinal epithelial cell barrier by increasing its integrity and
resistance to invasion. The findings of this research also sug-
gest that indole could be used to treat inflammatory intestinal
bowel disorders such as Crohn’s disease by enhancing the
epithelial cell barrier and dampening inflammation.
6.2. Interkingdom Signaling within the Gastrointestinal Tract.
Catecholamines such epinephrine and norepinephrine are
key players in mediating acute host stress. Half of the nore-
pinephrine in the human body is produced by the neuroen-
docrine system within the gastrointestinal tract. Through
the original investigations by Lyte and colleagues it has now
become established that bacteria can sense and respond to
host produced signaling molecules such as norepinephrine
and epinephrine [188, 189].These findings have given birth to
new field, aptly coined by Lyte as “microbial endocrinology”
(Figure 4) [190].
Microbiota Play a Pivotal Role in the Production of Cate-
cholamines. Catecholamines are produced by the neuroen-
docrine system within the gastrointestinal tract and it was
believed the resident commensals played no role in this pro-
cess. To determine whether the intestinal microbiota had an
impact on catecholamine production, Asano and colleagues
have overcome some major technical challenges and deter-
mined the physical levels of catecholamines norepinephrine
and dopamine using HPLC [191]. Using pathogen-free mice,
germ-free mice, and gnotobiotic mice, the authors deter-
mined the catecholamine levels in the gastrointestinal tract
of these mice. Their studies revealed that pathogen-free
mice had elevated levels of catecholamines when compared
to germ-free mice, which had no intestinal microbiota.
However, the introduction of either: specific pathogen-free
mice fecal bacteria, E. coli, or Clostridium species into germ-
freemice resulted in a remarkable increase in the levels of bio-
logically active dopamine and norepinephrine. Furthermore,
the authorswent on to observe that anE. colimutant unable to
produce𝛽-glucuronidasewas no longer able to raise the levels
of free biologically active catecholamines, thus suggesting the
bacterial enzyme plays a key role in the hormone maturation
process [191].This powerful comparative approach has vividly
revealed that the resident gut microbiota and the bacterial
enzyme 𝛽-glucuronidase have pivotal roles in the production
of biologically active catecholamines in the gastrointestinal
tract of the host.
Catecholamines in the Gastrointestinal Tract Regulate the Vir-
ulence of Salmonella.The gastrointestinal pathogen enterohe-
morrhagic Escherichia coli (EHEC) harbors a pathogenicity
island named the locus of enterocyte effacement (LEE). A
relatively new bacterial autoinducer has been reported, AI-3,
which stimulates the expression of the LEE virulence operon
in EHEC colitis.The sensing of AI-3 and signaling takes place
through the two-component signal transduction systems
QseBC and QseEF. These two-component systems regulate
virulence by modulating the expression of the LEE locus
[192, 193]. Astonishingly the catecholamines epinephrine and
norepinephrine can imitate the same biological effects of
AI-3 [192, 193]. Furthermore, 𝛼- and 𝛽-adrenergic receptor
antagonists can block the signaling.
These hormones also have an impact on the virulence
of Salmonella [163, 174, 194, 195]. Lipopolysaccharide is
an important molecule in the outer membranes of Gram-
negative bacteria and is subject to modification to help
adapt the bacterium to survive in different environments.
For example, the structure of LPS can be modified by the
pmr operon in Salmonella to adapt to different environments;
for example, in the gastrointestinal tract Paneth cells are
an important source of antimicrobial peptides. The pmr
operon confers resistance to antimicrobial peptides such as
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polymyxin B. If Salmonella are exposed to epinephrine and
subsequently challenged with polymyxin B, they become
more sensitive to the effects of this cationic antimicrobial
peptide [196]. However, the effect is fully reversible with the
addition of propranolol, a 𝛽-adrenergic blocker [196]. The
phenotype was independent of QseC, and through genetic
screens the BasSR two-component signal transduction sys-
tem was identified as being essential for this observation.The
LPS modifying enzymes PmrF and PagL are down-regulated
by epinephrine leading to an altered LPS chemotype. These
modifications in the structural configuration of LPS can
increase the sensitivity of the pathogen to antimicrobial
peptides, and also subdue the host inflammatory responses
as the modified LPS now reduces activation of the TLR-4
receptors [197].
The exclusively human pathogen S. Typhi can sense
and respond to catecholamine hormones and release the
toxin HlyE in outer membrane vesicles [198]. The signaling
cascades involve the two-component system CpxAR, with
increased expression of the sRNA micA and the RNA chap-
erone Hfq. This complex is believed to block the translation
of the ompA mRNA leading to reduced amounts of OmpA
in the outer membrane. This facilitates the release of outer
membrane vesicles containing HlyE [163, 194, 198]. From
the above examples, adrenergic signaling is clearly a double-
edged sword, which can provide benefits to the pathogen but
also on occasions to the host.
Fucose Sensing and Intestinal Colonization. B. thetaiotaomi-
cron is believed to possess fucosidases, which cleave fucose
from glycans such as mucin [199, 200]. Very recently it has
been reported that fucose can be sensed by the gastrointesti-
nal pathogen EHEC to regulate the expression of virulence
genes located within the LEE locus [201]. Expression of genes
in this locus is activated by the bacterial signal AI-3 and
host catecholamines as described above. Sensing of fucose
is mediated by a two-component system FusKR located on
the pathogenicity island OI-20 and appears to downregulate
expression of the LEE locus [201]. Furthermore, QseBC
and QseEF repress the expression of FusKR. These findings
suggest that EHEC is able to sense fucose produced by the
intestinal mucosa and subsequently modulate the expression
of virulence genes [201]. The rationale behind this reciprocal
regulation is puzzling, as the catecholamines and AI-3 signal
would be expected to be in very similar locations as the
fucose signal. Clearly further research is required to defini-
tively answer this question and also whether other enteric
pathogens such as S. Typhimurium are able to sense and
respond to fucose to modulate virulence gene expression.
7. Concluding Remarks and
Future Perspectives
Salmonella possess an armory of virulence factors to enable
efficacious infection of their hosts. Many of these virulence
factors protect the pathogen against host defenses and enable
Salmonella to invade and colonize mammalian tissues. Cen-
tral to these processes are the SPI-1 and SPI-2 T3SSs, which
have been acquired by ancestor strains through horizontal
gene transfer. There are a wealth of interactions between
Salmonella, the microbiota, and the gastrointestinal tract.
In contrast to 𝑆. Typhi, it is believed that S. Typhimurium
deliberately engages the host inflammatory response through
the SPI-1 and SPI-2 T3SSs.The inflamed intestine provides S.
Typhimurium with competitive growth advantages over the
resident microbiota, by enabling the generation of unique
electron acceptors and the subsequent utilization of new sub-
strates by the pathogen. S. Typhimurium can thus overcome
“nutritional immunity” by strategically modifying its imme-
diate environment enabling them to efficaciously outcompete
the resident microbiota. It is essential to determine the con-
tents of the inflamed intestine by metabolomics to facilitate
the identification of potential substrates and understand
how Salmonella manipulate the nutritional environment of
the gastrointestinal tract. Anaerobic respiration could also
provide a therapeutic target to control infections, and this
needs to be explored.
The intestine provides a very rich and dense ecosys-
tem enabling complex signaling between the host gastroin-
testinal cells, the resident microbiota, and invading bac-
terial pathogens. Bacteria generate a plethora of signaling
molecules and through their intimate interactionswithmam-
malian hosts have acquired the abilities to intercept host
signals.Metabolomic approaches to comprehensively analyze
intestinal contents may facilitate the identification of such
signalingmolecules. Understanding these elaborate signaling
cascades will be central to gaining a full understanding
of the processes required for maintaining good health and
preventing disease.
The present research at understanding the interactions
between the host cells, microbiota, and bacterial pathogens
has been limited to model organisms. These models have
proved very valuable but have limitations. Future research
should aim to examine these interactions directly within
the natural hosts for Salmonella, from livestock to humans.
The rapid technological advances taking place in rRNA
sequencing aswell aswhole-genome sequencingwill facilitate
these systems biology based approaches. Investigators are
now shifting their objectives from collecting a descriptive
analysis of the microbiota community composition and their
associations with health and disease to delivering more
fundamental mechanistic insights into the dynamic interac-
tions between the host, resident microbiota, and invading
pathogens.
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